US WorldMeds

US WorldMeds is a specialty pharmaceutical company headquartered in Kentucky. Its mission is to develop, license, and commercialize unique and significant specialty drugs to meet unmet medical needs or overcome limitations of existing products. US WorldMeds was founded on March 23, 2001, by current CEO Paul Breckinridge ("Breck" Jones), staying true to its founder’s original vision of becoming a substantial global enterprise while maintaining close connections and the ability to leverage local and experienced talent. US WorldMeds remains committed to growing as a leading corporate citizen at its Louisville headquarters, satellite offices, and manufacturing facilities, providing strong innovative drug products and high-quality job opportunities for future generations.